Regenerative Sciences, Inc., commonly referred to as Regenexx, is a pioneering leader in the field of regenerative medicine, headquartered in the United States. Founded in 2005, the company has established itself as a key player in the development of advanced stem cell therapies and regenerative treatments, primarily focusing on orthopaedic and musculoskeletal conditions. With a commitment to innovation, Regenexx offers a range of unique services, including non-surgical stem cell procedures that harness the body’s natural healing capabilities. Their proprietary techniques set them apart in the industry, providing patients with effective alternatives to traditional surgical interventions. Recognised for its significant contributions to regenerative medicine, Regenexx has built a strong market position, serving patients across various operational regions in the US. The company continues to lead the way in research and clinical applications, making strides in improving patient outcomes and advancing the field.
We don't have data for Regenerative Sciences, Inc., but we can show you information about their parent organization instead.
View parent company